Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris
Open accessPublished version of a preprint
The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index; 23 of the 42 sources its claims cite were checked for support.
Abstract
GCN5 depletion and loss of histone H3 acetylation downregulate key genes involved in ergosterol biosynthesis and drug efflux and regulate cell wall integrity and echinocandin resistance through calcineurin signaling and Cas5.
Overview
CoChat Summary
TL;DR
This study systematically examines histone H3 post-translational modification writers in *Candida auris* and identifies the acetyltransferase Gcn5 as a key regulator of antifungal resistance and virulence. Gcn5 inhibition with CPTH2 synergizes with caspofungin in vitro and in vivo, supporting Gcn5 as a potential therapeutic target.
Key findings
- GCN5 deletion in *C. auris* increased sensitivity to echinocandins, azoles, and polyenes; RNA-seq of WT versus gcn5Δ identified 975 differentially expressed genes (517 upregulated, 458 downregulated), with GSEA showing enrichment of ergosterol biosynthesis (NES 2.43, nominal and FDR-adjusted p < 0.0001).
- Gcn5 regulates azole resistance via ergosterol biosynthesis genes (ERG11, ERG1, ERG3, ERG25, UPC2) and drug efflux pumps (CDR1, SNQ2, MDR1), and regulates echinocandin resistance through the calcineurin pathway and transcription factor Cas5; gcn5Δ showed cell wall defects and elevated Hog1, Mkc1, and Cek1 phosphorylation.
- In infection models, GCN5 deletion reduced virulence in *Galleria mellonella* and immunosuppressed mice, with higher survival and lower organ fungal burden; CPTH2 plus caspofungin showed synergy (FICI < 0.5) against most *C. auris* clades except clade II and reduced fungal burden in kidneys and liver compared with caspofungin alone.
- CPTH2 inhibited *C. auris* Gcn5 at 1 µM versus 400 µM in mammalian cells; in mice, CPTH2 at 10, 20, or 40 mg/kg/day for 4 days caused no weight loss and no significant changes in ALT, AST, CREA, BUN, or LDH.
Methods
- Genetic knockouts and complementation were constructed in *C. auris* strains CBS12767 and yCB799; assays included Western blot for histone H3 acetylation/methylation, qRT-PCR, RNA-seq, ChIP-qPCR, CLSI M27-A4 broth microdilution, checkerboard assays, time-kill curves, Rhodamine 6G efflux, Calcofluor White chitin staining, and MAPK phosphorylation Western blots.
- Infection models used *Galleria mellonella* larvae and immunosuppressed ICR or C57BL/6 mice; outcomes included survival curves and fungal burden in organs after treatment with caspofungin, fluconazole, CPTH2, or combinations.
- Statistical analyses used GraphPad PRISM 9.4.1; RNA-seq differential expression used DESeq2 with adjusted p < 0.05 and |log2 fold change| > 1, and GO enrichment used clusterProfiler.
Limitations
- The paper states that the exact mechanisms by which Gcn5 influences pathogenicity remain partially elucidated, that further research is needed to confirm safety observations, and that site-directed mutagenesis is needed to explore specific Gcn5-regulated histone H3 acetylation sites.
- The paper notes that whether prolonged CPTH2 exposure leads to evolved resistance within Gcn5 itself or activation of compensatory pathways remains an open question; it also states that how Gcn5 regulates Cna1 and whether Cas5 overexpression or phosphorylation-site mutations restore echinocandin resistance in cna1Δ mutants require further study.
- The paper reports that CPTH2 plus caspofungin did not significantly affect spleen or lung fungal burden and did not improve survival or survival time in immunosuppressed mice infected with yCB799; synergy was not observed in clade II, and the study did not involve sex-based analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
15 Valid · 0 Not valid · 7 Not checked · 147 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies have demonstrated the critical role of histone H3 PTMs, such as methylation and acetylation, in driving both drug resistance and pathogenicity in human fungal pathogens.”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Introduction
What the sources say
- Partly supportedcites [25] Shivarathri, R. et al. The fungal histone acetyl transferase Gcn5 controls virulence of the human pathogen Candida albicans through multiple pathways. Sci. Rep. 9, 9445 (2019). sourceExperimental — accuracy not yet measured
The Introduction links histone-modifying acetyltransferases and deacetylases to fungal virulence, and the Abstract reports that loss of GCN5 reduces Candida albicans virulence and increases caspofungin susceptibility. The Discussion proposes histone H3 acetylation as a mechanism, but presents it as speculation; the paper does not establish a role for H3 methylation in drug resistance or pathogenicity. No page numbers are available in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [26] Lin, C.-J., Yang, S.-Y., Hsu, L.-H., Yu, S.-J. & Chen, Y.-L. The Gcn5-Ada2-Ada3 histone acetyltransferase module has divergent roles in pathogenesis of Candida glabrata. Med. Mycol. 61, myad004 (2023). source
- Partly supportedcites [27] Yu, C. K. et al. SAGA Complex subunit Hfi1 is important in the stress response and pathogenesis of Cryptococcus neoformans. J. Fungi 9, 1198 (2023). sourceExperimental — accuracy not yet measured
Results §3.5 reports that deleting HFI1 reduced H3K14 and H3K18 acetylation, while Results §3.2 and the Discussion report altered FK506 tolerance and reduced virulence in C. neoformans. But Results §3.5 found no change in H3K4 trimethylation, and the paper does not establish that H3 methylation and acetylation themselves drive both drug resistance and pathogenicity across human fungal pathogens. The claim is broader and more causal than these findings support. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [28] Lin, C.-J., Hou, Y.-H. & Chen, Y.-L. The histone acetyltransferase GcnE regulates conidiation and biofilm formation in Aspergillus fumigatus. Med. Mycol. 58, 248–259 (2020). source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Furthermore, C. auris can rapidly acquire resistance under the selective pressure of antifungal treatments or other specific conditions16–19.”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Introduction
What the sources say
- Not checked — no full text of the sourcecites [16] Bing, J. et al. Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris. Antimicrob. Agents Chemother. 65, e01466-20 (2020). source
- Partly supportedcites [17] Chan, W. et al. Induction of amphotericin B resistance in susceptible Candida auris by extracellular vesicles. Emerg. Microbes Infect. 11, 1900–1909 (2022). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports that adding extracellular vesicles from C. auris increased its amphotericin B minimum inhibitory concentration up to 16-fold. The Results (page unavailable) show this effect in an in vitro assay read after 24 hours, supporting a rapid change under that specific condition. The paper does not show that antifungal treatment's selective pressure caused the resistance or establish the claim across antifungal treatments generally. (LLM, conf=0.84)
- Partly supportedcites [18] Carolus, H. et al. Genome-wide analysis of experimentally evolved Candida auris reveals multiple novel mechanisms of multidrug resistance. mBio 12, e03333-20 (2021). sourceExperimental — accuracy not yet measured
The Results section, “C. auris clade II can acquire multidrug resistance rapidly in vitro” (page unavailable), reports that resistant clones emerged under antifungal-drug exposure, in one lineage after three days. The study supports rapid acquisition under antifungal selective pressure, but it does not show resistance arising under the claim’s alternative “other specific conditions.” (LLM, conf=0.86)
- Supportedcites [19] Codda, G. et al. In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022. Eurosurveillance 28, 2300161 (2023). source
The “In vivo evolution to echinocandin resistance” section reports resistant C. auris isolates emerging after 19 and 74 days of echinocandin exposure. The authors conclude that the resistance resulted from antifungal pressure, supporting the claim about acquisition under treatment. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“it has been reported that Gcn5-deficient mutants in both N. glabratus and C. neoformans exhibit significantly heightened sensitivity to the calcineurin inhibitor FK50653,54.”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Gcn5 is required for echinocandin resistance by regulating the expression of genes involved in calcineurin signaling pathway and cell wall integrity
What the sources say
- Not checked — no full text of the sourcecites [53] O’Meara, T. R., Hay, C., Price, M. S., Giles, S. & Alspaugh, J. A. Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host. Eukaryot. cell 9, 1193–1202 (2010). source
- Supportedcites [54] Yu, S. et al. Histone acetylation regulator Gcn5 mediates drug resistance and virulence of Candida glabrata. Microbiol. Spectr. 10, e00963–00922 (2022). source
The Results section reports that GCN5 deletion increased susceptibility to FK506 two- to fourfold in C. glabrata strains. This source supports the glabrata portion of the sentence; the C. neoformans portion is associated with the other citation. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“implicating Set2 as a negative regulator of azole resistance in C. auris, in line with observations in N. glabratus37”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Antifungal resistance in C. auris is linked to the activity of Lysine acetyltransferase Gcn5
What the sources say
- Supportedcites [37] Moirangthem, R., Kumar, K. & Kaur, R. Two functionally redundant FK506-binding proteins regulate multidrug resistance gene expression and govern azole antifungal resistance. Antimicrob. Agents Chemother. 65, 02415–02420 (2021). source
The paper reports that deleting CgSet2 decreases fluconazole susceptibility in C. glabrata, consistent with Set2 negatively regulating azole resistance there (section labeled ABSTRACT; page unavailable). In the citing sentence, this source is offered for the comparison with glabrata, not as evidence of the citing authors’ C. auris finding. (LLM, conf=0.89)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This finding suggests a potential compensatory mechanism, given the functional redundancy between FKS1 and FKS242–44.”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Gcn5 is required for echinocandin resistance by regulating the expression of genes involved in calcineurin signaling pathway and cell wall integrity
What the sources say
- Supportedcites [42] Katiyar, S. K. et al. Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance. Antimicrob. Agents Chemother. 56, 6304–6309 (2012). source
The citation supports the functional-redundancy premise, not the citing authors’ observation in gcn5Δ or their proposed mechanism. The Discussion (page not provided) states that Fks1 and Fks2 appear fully redundant for growth in C. glabrata. (LLM, conf=0.91)
- Supportedcites [43] Hou, X. et al. Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata. Emerg. Microbes Infect. 8, 1619–1625 (2019). source
The citation supports the functional redundancy between FKS1 and FKS2: the Discussion explicitly describes “Fks1-Fks2 redundancy.” The proposed compensatory mechanism in gcn5Δ is the citing authors’ interpretation, not a finding attributed to this source. (LLM, conf=0.91)
- Partly supportedcites [44] Frías-De-León, M. G. et al. Antifungal resistance in Candida auris: molecular determinants. Antibiotics 9, 568 (2020). sourceExperimental — accuracy not yet measured
Section 6 (Echinocandins; page not provided) says FKS1 and FKS2 encode the catalytic subunit of the same enzyme and describes homologous regions in the two genes. That supports overlapping roles, but the paper does not establish functional redundancy in the sense of one gene compensating for the other. The proposed mechanism is the citing authors’ interpretation, not a finding reported by this source. (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
115 more claims · 4 with their cited sources checked
Create a free account to see all 169 claims and every source verdict.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 17
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Evaluating the safety of targeting Gcn5 for antifungal therapy against C. auris infections
“Finally, CPTH2 was administered intravenously at doses of 10, 20, or 40 mg/kg/day to C57BL/6 mice over four consecutive days”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Evaluating the safety of targeting Gcn5 for antifungal therapy against C. auris infections
“d Body weight monitoring in mice receiving daily intraperitoneal injections of 10, 20, or 40 mg/kg CPTH2, or solvent control, for 4 days (n = 4).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Targeted inhibition of Gcn5 synergizes with CAS against C. auris in vitro and in vivo
“l Fungal burden measured in the spleens and liver of mice infected with yCB799 after 6 treatments with CPTH2 (10 mg/kg, n = 6; 40 mg/kg, n = 8) and CAS (10 mg/kg), either alone or in combination.”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Targeted inhibition of Gcn5 synergizes with CAS against C. auris in vitro and in vivo
“the combination of CPTH2 and CAS markedly reduced fungal burden in the kidneys and liver compared to CAS alone (Fig. 7l).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Methods > Strains Construction
“For constructing the LEU2 and GCN5 double knockout strain, we first used the SAT1-Flipper system to construct the gcn5Δ strain and excised the SAT1-Flipper cassette under 2% maltose induction. Subsequently, the NAT1 resistance cassette was used to knockout the SET1 gene.”
§ Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris > Results > Antifungal resistance in C. auris is linked to the activity of Lysine acetyltransferase Gcn5
“Confirmatory evidence was obtained by creating a double knockout strain (leu2Δgcn5Δ) through deletion of both LEU2 and GCN5”
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Histone PTMs play a pivotal role in modulating chromatin structure, thereby in fl uencing DNA accessibility 21,22 .”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011 · cited 1×
“Histone PTMs play a pivotal role in modulating chromatin structure, thereby in fl uencing DNA accessibility 21,22 .”
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845 · cited 1×
“Histone acetyltransferase Gcn5 has been previously recognized as a positive regulator of gene expression through its interaction with target promoters 38 .”
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 1×
“Recent studies on the multidrug resistance of C. auris have revealed that over 90% of clinical isolates areresistant to fl uconazole, 30-41% areresistant to two classes of antifungal drugs, and approximately 4% are resistant to three or more 5,14,15 .”
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555 · cited 1×
“Currently, only three major classes of antifungal drugs, including azoles (e.g., fl uconazole), polyenes (e.g., amphotericin B), and echi-nocandins (e.g., caspofungin), are available in clinical practice for the treatment of invasive fungal infections 12,13 .”
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179 · cited 1×
“Currently, only three major classes of antifungal drugs, including azoles (e.g., fl uconazole), polyenes (e.g., amphotericin B), and echi-nocandins (e.g., caspofungin), are available in clinical practice for the treatment of invasive fungal infections 12,13 .”
Cell Wall Integrity Signaling in Saccharomyces cerevisiae
Levin, D. E. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.262-291.2005 · Cited by 1,136 · cited 1×
“Moreover, the transcription factor Cas5 acts as a regulator of resistance to the echi-nocandin caspofungin in C. albicans , with studies showing that genes regulated by Cas5 in response to cell wall stress are also linked to calcineurin 48,51,52 .”
Research works printed but not linked: 2
- Bing, J. et al. Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris. Antimicrob. Agents Chemother. 65, 01466–01420 (2020). · DOI · Paper page
- Yu, S. et al. Histone acetylation regulator Gcn5 mediates drug resistance and virulence of Candida glabrata. Microbiol. Spectr. 10, e0096322 (2022). · DOI · Paper page
Cited by
New antifungal strategies and drug development against WHO critical priority fungal pathogens
Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., & Tan, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662442 · Cited by 53
“Genetic exchanges and epigenetic modi fi cations further contribute to rapid resistance development (Meng et al., 2024; Zajac et al., 2025; Zhang et al., 2025).”
White-Brown switching controls phenotypic plasticity and virulence of Candida auris
Phan-Canh, T., Jenull, S., Bitencourt, T. A., Seiser, S., Moser, D., Motamedi, M., Chowdhary, A., Elbe‐Bürger, A., & Kuchler, K. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115976 · Cited by 24
Candida auris skin tropism and antifungal resistance are mediated by carbonic anhydrase Nce103
Phan-Canh, T., Coman, C., Lackner, M., Troppmair, N., Müller, C., Cerbu, D., Seiser, S., Penninger, P., Tsymala, I., Khunweeraphong, N., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02189-z · Cited by 16
“For the conditional deletion of NCE103 and CYR1 in AR387, a plasmid pCB323 containing the tet-Off system 67 , assembled with the NAT1 marker optimized for C. auris , was used.”
Resilience in Resistance: The Role of Cell Wall Integrity in Multidrug-Resistant Candida
Banda-Flores, I. A., Torres‐Tirado, D., Mora-Montes, H. M., Pérez‐Flores, G., & Pérez-García, L. A. (2025) · Journal of Fungi · doi:10.3390/jof11040271 · Cited by 17
Antifungal Activity of Natural Thymol: Advances on Molecular Mechanisms and Therapeutic Potential
Chen, C., Liu, L., Tang, S., Li, D., & Dai, C. (2026) · Biomolecules · doi:10.3390/biom16010149 · Cited by 22
“Unfortunately, some fungal pathogens, such as Candida , Cryptococcus , and Aspergillus , exhibited potential resistance, resulting in a decreasing number of clinically available drugs [14–16].”
Self-citation
Metadata
- Authors
- Zhang, Y., Zeng, L., Huang, X., Wang, Y., Chen, G., Moses, M., Zou, Y., Xiong, S., Xue, W., Dong, Y., Tian, Y., Guan, M., Hu, L., Yin, Z., Zhou, D., Huang, X., & Chen, C.
- Affiliations
- Nanchang University (CN)
- Chinese Academy of Sciences (CN)
- Chinese People's Armed Police Force (CN)
- Shanghai Medical College of Fudan University (CN)
- Academy of Military Medical Sciences (CN)
- Corresponding author
- Huang, Xinhua
- Zhou, Dongsheng
- Huang, Xiaotian
- Chen, Changbin
- ORCID
- Venue
- Nature Communications
- Published
- 2025-05-20
- Volume
- 16
- Issue
- 1
- Pages
- 4668-4668
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC12092656
- OpenAlex
- W4410521054
- Cited by
- 33
- References
- 80
- Citations by year
- 2026: 23 · 2025: 10
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (32060040, 32170195, 32460049)
- Chinese Academy of Sciences
- Government of Jiangsu Province
- Fudan University
- Nanchang University
- Stockholms Universitet
- Science for Life Laboratory
- Huashan Hospital
- Recruitment Program of Global Experts
- State Key Laboratory of Pathogen and Biosecurity
- Institute of Microbiology, Chinese Academy of Sciences
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, antifungal resistance, histone acetylation, GCN5, Rtt109, histone methylation, Set1, Set2, Dot1, ergosterol biosynthesis, drug efflux, azole susceptibility, echinocandin resistance, calcineurin signaling, cell wall integrity, fungal virulence, epigenetic drug targets, invasive fungal infections
- MeSH terms
- Caspofungin, Candida auris, Acetylation, Animals, Antifungal Agents, Candidiasis, Cell Wall, Fungal Proteins, Histones, Humans, Microbial Sensitivity Tests, Moths, Virulence, Gene Expression Regulation, Fungal, Drug Resistance, Fungal, Epigenesis, Genetic, Mice, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris. https://app.cochat.ai/papers/10.1038/s41467-025-59898-6
- The paper
- Zhang, Y., Zeng, L., Huang, X., Wang, Y., Chen, G., Moses, M., Zou, Y., Xiong, S., Xue, W., Dong, Y., Tian, Y., Guan, M., Hu, L., Yin, Z., Zhou, D., Huang, X., & Chen, C. (2025). Targeting epigenetic regulators to overcome drug resistance in the emerging human fungal pathogen Candida auris. Nature Communications. https://doi.org/10.1038/s41467-025-59898-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.